ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer
Photo by Wengang Zhai on Unsplash

ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer

The American Society of Clinical Oncology (ASCO) held its ASCO Gastrointestinal Cancers Symposium from January 18-20, 2024. During the Symposium, doctors, researchers, scientists, and other stakeholders discussed innovative science and…

Continue Reading ASCO GI 2024: Oral Antroquinonol Improved Overall Survival Rates in Metastatic Pancreatic Cancer
Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates
source: pixabay.com

Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates

  Researchers have been able to identify similarities in outcomes between colorectal liver metastases that cannot be completely removed by surgery (unresectable) and patients with the KRAS mutation. Surgical resection…

Continue Reading Patients with Unresectable Colorectal Liver Metastases and KRAS Mutations Show Reduced Response Rates